A new report from the Consumer Policy Center found that Compass controls at least 30% of real estate transactions in five major cities.

In the Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with biliary tract cancer, the prespecified event threshold of 80% overall survival (OS) events was ...

Private equity firm Compass Diversified (NYSE:CODI) is expected to be announcing earnings results this Tuesday afternoon. Here’s what investors should know. Compass Diversified missed analysts’ ...

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and ...

Compass Minerals International, Inc. (NYSE: CMP) will release earnings results for the fourth quarter after the closing bell on Monday, Dec. 8. Analysts expect the Overland Park, Kansas-based company ...

Based on a continuing trend of decreased mortality in the ongoing Phase 2/3 COMPANION-002 study of tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with advanced biliary tract cancer (BTC), ...

BOSTON, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, ...

BOSTON, March 05, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to ...